A blood and marrow transplant programme run by Texas Oncology, a large community cancer care network, at hospital-based centres across the state.
According to its website, Texas Oncology operates a Blood and Marrow Transplant Program described as restoring healthy blood cell production by replacing diseased cells. Texas Oncology is a large community oncology network, and the transplant programme is delivered from centres based within partner hospital campuses rather than from a single standalone site.
The general programme page reviewed gives only a brief description and does not itself list specific conditions treated, transplant types performed, or named clinicians. A location-specific page for the programme at Texas Oncology–Baylor Charles A. Sammons Cancer Center in Dallas gives an address and contact details but likewise does not name individual clinicians or state accreditation on the pages reviewed. Other sources referenced by the site indicate the programme operates at multiple Texas Oncology locations, including sites affiliated with Baylor and with St David's HealthCare and the Texas Transplant Institute in San Antonio, though the pages reviewed for this profile did not themselves confirm those details in full.
The site does not state whether autologous transplants (using the patient's own cells), allogeneic transplants (using donor cells), or both are offered at this location; a prospective patient would need to ask. No specific pricing is published; as a hospital-based cancer treatment programme, cost would depend on diagnosis and insurance coverage.
The pages reviewed do not list specific conditions treated by this programme.
The pages reviewed describe blood and marrow transplantation only in general terms and do not state which transplant types (autologous or allogeneic) are offered.
No individual clinicians are named on the pages reviewed.
The programme operates from Texas Oncology's hospital-affiliated cancer centres, including a location at Texas Oncology–Baylor Charles A. Sammons Cancer Center in Dallas. The site gives limited detail about individual premises.
No pricing is published. As a hospital-affiliated cancer treatment programme, cost would depend on diagnosis and insurance coverage, which a patient would need to discuss with the centre directly.
Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.